Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Acasti Pharma (ACST) has a market cap of $34.171 million USD. According to our data, Acasti Pharma is ranked No.8360 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Dec 27, 2024 | $34.17 M |
28.37%
|
| Dec 29, 2023 | $29.30 M |
-3.86%
|
| Dec 30, 2022 | $30.48 M |
-60.24%
|
| Dec 31, 2021 | $76.66 M |
-51.54%
|
| Dec 31, 2020 | $0.16 B |
-86.73%
|
| Dec 31, 2019 | $1.19 B |
194.51%
|
| Dec 31, 2018 | $0.40 B |
-11.76%
|
| Dec 29, 2017 | $0.46 B |
-24.58%
|
| Dec 30, 2016 | $0.61 B |
-50.98%
|
| Dec 31, 2015 | $1.24 B |
-49.00%
|
| Dec 31, 2014 | $2.43 B |
-60.00%
|
| Dec 31, 2013 | $6.08 B |
-41.91%
|
| Dec 31, 2012 | $10.47 B |
62.29%
|
| Dec 30, 2011 | $6.45 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
 Matinas BioPharma
MTNB
|
$2.92 M |
0.000 M
|
USA
|
 Corbus Pharmaceuticals
CRBP
|
$0.14 B |
-0.000 M
|
USA
|
 MannKind Corp
MNKD
|
$1.70 B |
0.000 M
|
USA
|
 Omeros Corporation
OMER
|
$0.54 B |
0.000 M
|
USA
|
 Cytokinetics
CYTK
|
$5.53 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 Arrowhead Pharmaceuticals
ARWR
|
$2.45 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
| Market Cap | = | ACST Stock Price | * | ACST Shares Outstanding |
| = | $3.71 | * | 10.14 M | |
| = | $34.17 M |